- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/573 - Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
Patent holdings for IPC class G01N 33/573
Total number of patents in this class: 2313
10-year publication summary
|
302
|
258
|
174
|
189
|
184
|
153
|
164
|
148
|
140
|
48
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| aTyr Pharma, Inc. | 158 |
51 |
| Pangu BioPharma Limited | 106 |
50 |
| The Regents of the University of California | 18943 |
42 |
| Takeda Pharmaceutical Company Limited | 2961 |
33 |
| The Johns Hopkins University | 5377 |
28 |
| Genentech, Inc. | 3742 |
20 |
| Promega Corporation | 548 |
17 |
| Board of Regents, The University of Texas System | 5370 |
16 |
| Centre National de La Recherche Scientifique | 9632 |
15 |
| F. Hoffmann-La Roche AG | 7958 |
14 |
| Abbott Laboratories | 2542 |
14 |
| Massachusetts Institute of Technology | 9795 |
14 |
| President and Fellows of Harvard College | 5792 |
14 |
| Dana-Farber Cancer Institute, Inc. | 2455 |
14 |
| National Research Council of Canada | 1545 |
14 |
| Yale University | 2204 |
14 |
| Bayer Healthcare AG | 271 |
12 |
| California Institute of Technology | 3884 |
12 |
| Astute Medical, Inc. | 173 |
12 |
| City of Hope | 943 |
11 |
| Other owners | 1896 |